Skip to Content

U.S. to Get Fewer Vials of Pfizer COVID-19 Vaccine

MONDAY, Jan. 25, 2021 -- Pfizer will provide fewer vials of its COVID-19 vaccine to the United States in the coming months after it was discovered that it had previously shipped extra doses.

In December, U.S. pharmacists found that they could get an extra dose out of Pfizer vials that were supposed to contain only five doses, The New York Times reported.

The U.S. Food and Drug Administration has agreed with Pfizer's demand to formally acknowledge that those vials contained six doses instead of five. That means that Pfizer will count the extra dose toward its previous commitment of 200 million doses for the United States by the end of July and will provide fewer vials by that time than had been anticipated, The Times reported.

But pharmacists at some vaccination sites say it is a challenge to reliably extract the extra dose out of vials. Doing so requires a specialty syringe. "Now there's more pressure to make sure that you get that sixth dose out," Michael Ganio, senior director for pharmacy practice and quality at the American Society of Health-System Pharmacists, told The Times.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Posted: January 2021

Read this next

Walmart Expands COVID-19 Vaccination Program

MONDAY, March 1, 2021 -- Walmart said it will expand its COVID-19 vaccination program to more than 1,400 pharmacies in 35 states. The retailer will also partner with local...

AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants

MONDAY, March 1, 2021 -- A COVID-19 vaccine still awaiting U.S. Food and Drug Administration approval may prove to be a powerful weapon in fighting the pandemic, according to its...

J&J COVID-19 Vaccine Granted Emergency Use Authorization

MONDAY, March 1, 2021 -- The Janssen COVID-19 vaccine received the third emergency use authorization for a vaccine to prevent COVID-19, the U.S. Food and Drug Administration...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.